14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Apr 27, 2021 $2.84 $3.07 $2.78 $2.84 2 271 650
Apr 26, 2021 $2.56 $2.68 $2.56 $2.61 377 117
Apr 23, 2021 $2.46 $2.60 $2.43 $2.55 450 713
Apr 22, 2021 $2.57 $2.57 $2.43 $2.51 499 572
Apr 21, 2021 $2.42 $2.63 $2.32 $2.53 969 861
Apr 20, 2021 $2.47 $2.55 $2.28 $2.34 575 825
Apr 19, 2021 $2.52 $2.52 $2.33 $2.40 472 752
Apr 16, 2021 $2.63 $2.63 $2.42 $2.51 407 986
Apr 15, 2021 $2.63 $2.66 $2.51 $2.60 326 378
Apr 14, 2021 $2.64 $2.78 $2.56 $2.58 462 265
Apr 13, 2021 $2.72 $2.73 $2.45 $2.61 1 118 375
Apr 12, 2021 $2.84 $2.84 $2.65 $2.72 322 580
Apr 09, 2021 $2.95 $2.95 $2.80 $2.81 330 749
Apr 08, 2021 $3.02 $3.07 $2.93 $2.97 304 684
Apr 07, 2021 $2.99 $3.53 $2.93 $3.03 2 138 957
Apr 06, 2021 $3.00 $3.02 $2.95 $2.99 246 570
Apr 05, 2021 $3.05 $3.05 $2.95 $3.02 108 108
Apr 01, 2021 $3.03 $3.05 $2.96 $3.05 160 160
Mar 31, 2021 $2.91 $3.03 $2.91 $3.02 154 510
Mar 30, 2021 $2.81 $2.95 $2.80 $2.90 156 254
Mar 29, 2021 $3.07 $3.07 $2.80 $2.83 392 796
Mar 26, 2021 $2.98 $2.99 $2.84 $2.98 214 564
Mar 25, 2021 $2.94 $2.99 $2.81 $2.96 309 586
Mar 24, 2021 $3.16 $3.16 $2.95 $2.97 303 823
Mar 23, 2021 $3.32 $3.32 $3.05 $3.10 338 656
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT